
|Poll|January 27, 2023
Poll: How familiar are you on the approval process for biosimilar drugs in comparison to new drug applications to the FDA?
Author(s)OT Staff Reports
Let us know how familiar are you on the approval process for biosimilar drugs compared with new drug applications to the FDA. The poll will be open until February 28, 2023.
Advertisement
How familiar are you on the approval process for biosimilar drugs in comparison to new drug applications to the FDA?
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
First patient treated in ViaLase’s IDE trial
2
Formosa Pharmaceuticals and Rxilient sign licensing and commercialization agreement for APP13007
3
Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD
4
PainReform launches development plan for OcuRing-K, readies phase 2 trial
5















































.png)


